Furthermore, vieloplain F revealed that it is not a P-gp (P-glycoprotein) substrate; therefore, vieloplain F is not susceptible to the efflux mechanism of P-gp, which many cancer cell lines utilize as a drug resistance mechanism. The gene discussed is PGP; the disease is cancer.